Introduction of peanut in high risk infants
AbstractPeanut allergy is a major public health concern estimated to affect between 0.5-2% of children,1-3 and is one of the most common causes of food-related anaphylaxis.4 Peanut allergy usually begins early in life and tends to be persistent in at least 80% of cases.5 There is no known “cure” for peanut allergy, though specific oral tolerance induction is being used to try and desensitise patients, but is in most cases not leading to permanent tolerance. Therefore, much attention has been paid recently to investigate strategies for the prevention of peanut allergy. Prevention of peanut allergy would have a significant impact on the individual as well as, potentially, at a public health level in view of recent evidence of an increase in peanut allergy in many parts of the world.2,4
How to Cite
Gray, C. (2018). Introduction of peanut in high risk infants. South African Journal of Clinical Nutrition, 31(2), 26-29. Retrieved from http://www.sajcn.co.za/index.php/SAJCN/article/view/1333
SASPEN Case Study
Material submitted for publication in the South African Journal of Clinical Nutrition (SAJCN) is accepted provided it has not been published elsewhere. Copyright forms will be sent with acknowledgement of receipt and the SAJCN reserves copyright of the material published.
The SAJCN does not hold itself responsible for statements made by the authors.